180
Participants
Start Date
May 22, 2020
Primary Completion Date
August 29, 2023
Study Completion Date
August 31, 2028
JenaValve Trilogy Heart Valve System
TAVR with JenaValve Trilogy Heart Valve System
New York-Presbyterian/ Columbia University Medical Center, New York
Allegheny-Singer Health Network, Pittsburgh
Lankenau, Wynnewood
MedStar Washington Hospital Center, Washington D.C.
University of Maryland Medical Center, Baltimore
Sentara Hospitals, Norfolk
Medical University of South Carolina, Charleston
Piedmont Healthcare, Atlanta
Emory University Hospital, Atlanta
Morton Plant/ BayCare Health, Clearwater
Methodist Le Bonheur Healthcare, Memphis
Ohio Health Research Institute, Columbus
Cleveland Clinic Foundation, Cleveland
The Christ Hospital, Cincinnati
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
Minneapolis Heart Institute/ Abbott Northwestern, Minneapolis
Cardiac Surgery Clinical Research Center Inc./ Advocate Aurora Health, Oak Lawn
Barnes-Jewish Hospital / Washington University, St Louis
Baylor Scott & White Research Institute, Dallas
Houston Methodist, Houston
Memorial Hermann - Texas Medical Center, Houston
Intermountain Medical Center Heart Institute, Salt Lake City
TMC HealthCare & PIMA Heart, Tucson
Cedars Sinai Medical Center, Los Angeles
Scripps Hospital, San Diego
California Pacific Medical Center Research Institute, San Francisco
Oregon Health & Science University, Portland
University of Washington, Seattle
Rutgers Robert Wood Johnson Medical School/ Rutgers Robert Wood University Hospital, Piscataway
Lead Sponsor
JenaValve Technology, Inc.
INDUSTRY